BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35804981)

  • 21. Comparison of the predictive performance of risk of malignancy indexes 1-4, HE4 and risk of malignancy algorithm in the triage of adnexal masses.
    Hada A; Han LP; Chen Y; Hu QH; Yuan Y; Liu L
    J Ovarian Res; 2020 Apr; 13(1):46. PubMed ID: 32334618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
    Dora SK; Dandapat AB; Pande B; Hota JP
    J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS).
    Sharma A; Apostolidou S; Burnell M; Campbell S; Habib M; Gentry-Maharaj A; Amso N; Seif MW; Fletcher G; Singh N; Benjamin E; Brunell C; Turner G; Rangar R; Godfrey K; Oram D; Herod J; Williamson K; Jenkins H; Mould T; Woolas R; Murdoch J; Dobbs S; Leeson S; Cruickshank D; Fourkala EO; Ryan A; Parmar M; Jacobs I; Menon U
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):338-44. PubMed ID: 22911637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vessel morphology depicted by three-dimensional power Doppler ultrasound as second-stage test in adnexal tumors that are difficult to classify: prospective diagnostic accuracy study.
    Sladkevicius P; Jokubkiene L; Timmerman D; Fischerova D; Van Holsbeke C; Franchi D; Savelli L; Epstein E; Fruscio R; Kaijser J; Czekierdowski A; Guerriero S; Pascual MA; Testa AC; Ameye L; Valentin L
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):324-334. PubMed ID: 32853459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women.
    Holcomb K; Vucetic Z; Miller MC; Knapp RC
    Am J Obstet Gynecol; 2011 Oct; 205(4):358.e1-6. PubMed ID: 21722869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative risk stratification of adnexal masses: can we predict the optimal surgical management?
    Rogers EM; Casadiego Cubides G; Lacy J; Gerstle JT; Kives S; Allen L
    J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):125-8. PubMed ID: 24560684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative Outcomes after Single-port Laparoscopic Removal of Adnexal Masses in Patients Referred to Gynecologic Oncology at a Large Academic Center.
    Moulton LJ; Jernigan AM; Michener CM
    J Minim Invasive Gynecol; 2017; 24(7):1136-1144. PubMed ID: 28673874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors.
    Carreras-Dieguez N; Glickman A; Munmany M; Casanovas G; Agustí N; Díaz-Feijoo B; Saco A; Sánchez B; Gaba L; Angeles MA; Pahisa J; Fernández-Galán E; Torné A; Fusté P
    Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. O-RADS MRI score: analysis of misclassified cases in a prospective multicentric European cohort.
    Thomassin-Naggara I; Belghitti M; Milon A; Abdel Wahab C; Sadowski E; Rockall AG;
    Eur Radiol; 2021 Dec; 31(12):9588-9599. PubMed ID: 34041567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
    Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of perfusion CT in the evaluation of adnexal masses.
    Singla V; Prabhakar N; Khandelwal N; Sharma G; Singh T; Aggarwal N; Radhika S
    J Obstet Gynaecol; 2019 Feb; 39(2):218-223. PubMed ID: 30257605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doppler sonography of adnexal masses: the predictive value of the pulsatility index in benign and malignant disease.
    Salem S; White LM; Lai J
    AJR Am J Roentgenol; 1994 Nov; 163(5):1147-50. PubMed ID: 7976891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
    Salvador S; Scott S; Glanc P; Eiriksson L; Jang JH; Sebastianelli A; Dean E
    J Obstet Gynaecol Can; 2020 Aug; 42(8):1021-1029.e3. PubMed ID: 32736853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses.
    Marret H; Sauget S; Giraudeau B; Brewer M; Ranger-Moore J; Body G; Tranquart F
    J Ultrasound Med; 2004 Dec; 23(12):1629-39; quiz 1641-42. PubMed ID: 15557306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ADNEX model to triage adnexal masses: An external validation study and comparison with the IOTA two-step strategy and subjective assessment by an experienced ultrasound operator.
    Viora E; Piovano E; Baima Poma C; Cotrino I; Castiglione A; Cavallero C; Sciarrone A; Bastonero S; Iskra L; Zola P
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():207-211. PubMed ID: 32146226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study.
    Froyman W; Landolfo C; De Cock B; Wynants L; Sladkevicius P; Testa AC; Van Holsbeke C; Domali E; Fruscio R; Epstein E; Dos Santos Bernardo MJ; Franchi D; Kudla MJ; Chiappa V; Alcazar JL; Leone FPG; Buonomo F; Hochberg L; Coccia ME; Guerriero S; Deo N; Jokubkiene L; Kaijser J; Coosemans A; Vergote I; Verbakel JY; Bourne T; Van Calster B; Valentin L; Timmerman D
    Lancet Oncol; 2019 Mar; 20(3):448-458. PubMed ID: 30737137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and ultrasound characteristics of surgically removed adnexal lesions with largest diameter ≤ 2.5 cm: a pictorial essay.
    Di Legge A; Pollastri P; Mancari R; Ludovisi M; Mascilini F; Franchi D; Jurkovic D; Coccia ME; Timmerman D; Scambia G; Testa A; Valentin L
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):648-656. PubMed ID: 28004457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adding a single CA 125 measurement to ultrasound imaging performed by an experienced examiner does not improve preoperative discrimination between benign and malignant adnexal masses.
    Valentin L; Jurkovic D; Van Calster B; Testa A; Van Holsbeke C; Bourne T; Vergote I; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2009 Sep; 34(3):345-54. PubMed ID: 19585547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of IOTA simple rules for adnexal masses classification: a comparison between two centers with different ovarian cancer prevalence.
    Ruiz de Gauna B; Rodriguez D; Olartecoechea B; Aubá M; Jurado M; Gómez Roig MD; Alcázar JL
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():10-4. PubMed ID: 26066289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.